CTSO vs NVST · rev $18.5M vs P/E 56, rev $1.44B
Cytosorbents Crp (CTSO) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
CTSO currently screens at market cap $28.8M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the CTSO and NVST stock pages for the full models.
Not investment advice.